AptarGroup, Inc. (NYSE:ATR) gets upgraded to Outperform by Robert W. Baird with a price target of $115.00

ME Staff
-
0

Analyst Ratings For AptarGroup, Inc. (NYSE:ATR)

Today, AptarGroup, Inc. (NYSE:ATR) stock received an upgrade by Robert W. Baird from Neutral to Outperform with a price target of $115.00.

There are 5 Hold Ratings, 3 Buy Ratings, 1 Sell Ratings, no Strong Buy Ratings on the stock.

The current consensus rating on AptarGroup, Inc. (NYSE:ATR) is Hold with a consensus target price of $104.4286 per share, a potential 2.48% upside.

Some recent analyst ratings include

  • 2/27/2019-AptarGroup, Inc. (NYSE:ATR) gets upgraded to Outperform by Robert W. Baird with a price target of $115.00
  • 2/22/2019-AptarGroup, Inc. (NYSE:ATR) had its Hold rating reiterated by KeyCorp
  • 2/22/2019-AptarGroup, Inc. (NYSE:ATR) gets downgraded to Sell by Vertical Research
  • 2/21/2019-AptarGroup, Inc. (NYSE:ATR) had its Outperform rating reiterated by William Blair
  • On 1/9/2019 Maritza Gomez Montiel, Director, sold 707 with an average share price of $93.58 per share and the total transaction amounting to $66,161.06.
  • On 11/8/2018 Stephen J Hagge, Director, sold 25,000 with an average share price of $104.92 per share and the total transaction amounting to $2,623,000.00.
  • On 9/4/2018 Monnas Giovanna Kampouri, Director, sold 12,667 with an average share price of $105.45 per share and the total transaction amounting to $1,335,735.15.
  • On 8/28/2018 Stephen J Hagge, Director, sold 25,000 with an average share price of $104.31 per share and the total transaction amounting to $2,607,750.00.
  • On 8/2/2018 Salim Haffar, Insider, sold 1,989 with an average share price of $103.37 per share and the total transaction amounting to $205,602.93.
  • On 7/31/2018 Stephen J Hagge, Director, sold 25,000 with an average share price of $102.33 per share and the total transaction amounting to $2,558,250.00.
  • On 7/30/2018 Robert Kuhn, CFO, sold 10,000 with an average share price of $101.24 per share and the total transaction amounting to $1,012,400.00.

About AptarGroup, Inc. (NYSE:ATR)
AptarGroup, Inc. provides a range of packaging, dispensing, and sealing solutions, primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates in three segments: Beauty + Home, Pharma, and Food + Beverage. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and household markets; and pumps and decorative components to the beauty market. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market. The Food + Beverage segment offers dispensing and non-dispensing closures, spray pumps, and aerosol valves to the food and beverage markets. The company also manufactures and sells elastomeric primary packaging components for injectable market, which include stoppers for infusion, antibiotic, lyophilization, and diagnostic vials; and pre-filled syringe components, such as plungers, needle shields, tip caps and cartridges, and dropper bulbs and syringe plungers. AptarGroup, Inc. sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. The company was founded in 1992 and is headquartered in Crystal Lake, Illinois.

Recent Trading Activity for AptarGroup, Inc. (NYSE:ATR)
Shares of AptarGroup, Inc. closed the previous trading session at 102,10 +0,80 0,79 % with 102.3 shares trading hands.